Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.12% | -172.06% | 2.74% | 55.74% | -0.20% |
| Total Depreciation and Amortization | 1.86% | -6.11% | -2.55% | -4.47% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.12% | 587.04% | 2.75% | -197.46% | 0.21% |
| Change in Net Operating Assets | -- | -- | 2.75% | -- | -- |
| Cash from Operations | 2.12% | 230.60% | 2.74% | -440.63% | -0.19% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 3.77% | -- | -- |
| Cash from Investing | -- | -- | 3.77% | -- | -- |
| Total Debt Issued | -- | -- | 0.00% | -- | -- |
| Total Debt Repaid | 0.00% | -2,381.12% | 0.00% | -3.70% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.10% | -204.95% | -2.74% | 2,510.48% | 0.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.11% | 239.08% | 2.75% | -276.25% | -0.18% |